BlackRock Fund Advisors - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 70 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q4 2016$28,758,000
+6.2%
1,025,225
+12.4%
0.01%
-16.7%
Q3 2016$27,080,000
+53.4%
911,788
+4.6%
0.01%
+50.0%
Q2 2016$17,654,000
+64.7%
871,793
+46.8%
0.00%
+100.0%
Q1 2016$10,722,000
-28.7%
594,012
+4.1%
0.00%
-33.3%
Q4 2015$15,031,000
+191.3%
570,657
+136.0%
0.00%
+200.0%
Q3 2015$5,160,000
-20.6%
241,810
-1.4%
0.00%
-50.0%
Q2 2015$6,497,000245,2550.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q2 2015
NameSharesValueWeighting ↓
TRV GP II, LLC 878,875$70,354,00045.87%
CVI Holdings, LLC 200,000$16,010,00015.16%
Foresite Capital Management III, LLC 467,682$37,438,0009.74%
Casdin Capital, LLC 848,648$67,934,0007.46%
BVF INC/IL 564,965$45,225,0005.06%
Ghost Tree Capital, LLC 240,000$19,212,0005.02%
DAFNA Capital Management LLC 119,718$9,583,0004.13%
HHLR ADVISORS, LTD. 1,498,516$119,956,0003.34%
Opaleye Management Inc. 130,000$10,407,0002.88%
Perceptive Advisors 1,271,054$101,748,0002.87%
View complete list of BLUEPRINT MEDICINES CORP shareholders